Public Access To FDA Compliance, Enforcement Data Would Grow Under New Proposals
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Transparency Task Force is floating ideas for making the agency’s compliance and enforcement data more accessible to the public.
You may also be interested in...
Regulatory News In Brief
FDA issues final rule on Strategic National Stockpile of devices, drugs and biologics. Commissioner adopts proposals to make compliance data more transparent. More regulatory briefs.
Regulatory News In Brief
FDA enforcement activities available online
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.